Proving CME's Value

Proving CME's Value

The biggest concern facing Pharmaceutical industry CME professionals is how to prove their value within their companies, a proposition that's becoming much more difficult because of the increasing government scrutiny of commercially-supported CME, according to the results of a survey of attendees at the Pharmaceutical Alliance for CME member section meeting. The meeting was convened during the Alliance for CME an

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.